Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Agilon Health (AGL) Equity Average (2020 - 2025)

Agilon Health's Equity Average history spans 6 years, with the latest figure at $216.4 million for Q4 2025.

  • For Q4 2025, Equity Average fell 58.62% year-over-year to $216.4 million; the TTM value through Dec 2025 reached $216.4 million, down 58.62%, while the annual FY2025 figure was $298.8 million, 47.2% down from the prior year.
  • Equity Average reached $216.4 million in Q4 2025 per AGL's latest filing, down from $357.5 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $1.1 billion in Q3 2021 to a low of -$291.5 million in Q1 2021.
  • Average Equity Average over 5 years is $722.6 million, with a median of $724.2 million recorded in 2023.
  • Peak YoY movement for Equity Average: surged 546.12% in 2021, then tumbled 58.62% in 2025.
  • A 5-year view of Equity Average shows it stood at $1.1 billion in 2021, then dropped by 4.2% to $1.1 billion in 2022, then fell by 27.91% to $766.3 million in 2023, then crashed by 31.76% to $522.9 million in 2024, then tumbled by 58.62% to $216.4 million in 2025.
  • Per Business Quant, the three most recent readings for AGL's Equity Average are $216.4 million (Q4 2025), $357.5 million (Q3 2025), and $454.6 million (Q2 2025).